HomeComparePSYGF vs BTI

PSYGF vs BTI: Dividend Comparison 2026

PSYGF yields 1574.80% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PSYGF wins by $1094146078.82M in total portfolio value
10 years
PSYGF
PSYGF
● Live price
1574.80%
Share price
$0.13
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1094146078.86M
Annual income
$972,648,549,767,836.50
Full PSYGF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — PSYGF vs BTI

📍 PSYGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPSYGFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PSYGF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PSYGF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSYGF
Annual income on $10K today (after 15% tax)
$133,858.27/yr
After 10yr DRIP, annual income (after tax)
$826,751,267,302,661.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, PSYGF beats the other by $826,751,267,300,279.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSYGF + BTI for your $10,000?

PSYGF: 50%BTI: 50%
100% BTI50/50100% PSYGF
Portfolio after 10yr
$547073039.45M
Annual income
$486,324,274,885,319.40/yr
Blended yield
88.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

PSYGF
No analyst data
Altman Z
-61.3
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSYGF buys
0
BTI buys
0
No recent congressional trades found for PSYGF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPSYGFBTI
Forward yield1574.80%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$1094146078.86M$37.8K
Annual income after 10y$972,648,549,767,836.50$2,802.29
Total dividends collected$1085342975.29M$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PSYGF vs BTI ($10,000, DRIP)

YearPSYGF PortfolioPSYGF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$168,180$157,480.31$11,301$601.08+$156.9KPSYGF
2$2,655,195$2,475,241.96$12,799$706.58+$2.64MPSYGF
3$39,363,107$36,522,048.09$14,527$832.38+$39.35MPSYGF
4$548,134,593$506,016,068.87$16,527$982.75+$548.12MPSYGF
5$7,171,846,637$6,585,342,622.60$18,846$1,162.95+$7171.83MPSYGF
6$88,200,293,754$80,526,417,852.20$21,545$1,379.49+$88200.27MPSYGF
7$1,019,911,005,360$925,536,691,043.00$24,694$1,640.41+$1019910.98MPSYGF
8$11,093,656,198,301$10,002,351,422,566.60$28,378$1,955.69+$11093656.17MPSYGF
9$113,549,092,609,754$101,678,880,477,571.69$32,702$2,337.79+$113549092.58MPSYGF
10$1,094,146,078,860,274$972,648,549,767,836.50$37,794$2,802.29+$1094146078.82MPSYGF

PSYGF vs BTI: Complete Analysis 2026

PSYGFStock

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.

Full PSYGF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this PSYGF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSYGF vs SCHDPSYGF vs JEPIPSYGF vs OPSYGF vs KOPSYGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.